Congress
← Go back to articlePublished on November 1, 2002 | http://doi.org/10.5867/medwave.2002.10.619
Lipid-lowering drugs: current status and controversies
Article download statistics
| Month | HTML Views | PDF Downloads |
|---|---|---|
| August 2022 | 1073 | 0 |
| September 2022 | 1548 | 0 |
| October 2022 | 1595 | 0 |
| November 2022 | 1645 | 0 |
| December 2022 | 566 | 0 |
| January 2023 | 786 | 0 |
| February 2023 | 1304 | 0 |
| March 2023 | 1241 | 0 |
| April 2023 | 32 | 0 |
| May 2023 | 299 | 0 |
| June 2023 | 855 | 0 |
| July 2023 | 845 | 0 |
| August 2023 | 901 | 0 |
| September 2023 | 687 | 0 |
| October 2023 | 1029 | 0 |
| November 2023 | 847 | 0 |
| December 2023 | 383 | 0 |
| January 2024 | 515 | 0 |
| February 2024 | 301 | 0 |
| March 2024 | 328 | 0 |
| April 2024 | 309 | 0 |
| May 2024 | 221 | 0 |
| June 2024 | 192 | 0 |
| July 2024 | 356 | 0 |
| August 2024 | 240 | 0 |
| September 2024 | 255 | 0 |
| October 2024 | 334 | 0 |
| November 2024 | 1165 | 0 |
| December 2024 | 133 | 0 |
| January 2025 | 86 | 0 |
| Total | 20071 |